Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W4AR
|
|||
| Former ID |
DIB004899
|
|||
| Drug Name |
KUR-211
|
|||
| Indication | Ulcer [ICD-11: CA02-CB40; ICD-10: K25-K27; ICD-9: 531-534] | Phase 2 | [1] | |
| Company |
Baxter international; kuros biosurgery
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fibrin (FG) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024804) | |||
| REF 2 | Clinical pipeline report, company report or official report of Kuros. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.